The Effect of Dapagliflozin on Rate of Kidney Function Decline in Patients with CKD: A Prespecified Analysis from the DAPA-CKD Trial

被引:0
|
作者
Heerspink, Hiddo J. L. [1 ,2 ]
Jongs, Niels [1 ]
Chertow, Glenn M. [3 ]
Langkilde, Anna Maria [4 ]
McMurray, John [5 ]
Correa-Rotter, Ricardo [6 ]
Rossing, Peter [7 ,8 ]
Sjostrom, David [4 ]
Stefansson, Bergur V. [4 ]
Toto, Robert D. [9 ]
Wheeler, David C. [10 ]
Greene, Tom [11 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[2] George Inst Global Hlth, Newtown, NSW, Australia
[3] Stanford Univ, Sch Med, Stanford, CA USA
[4] AstraZeneca, Gothenburg, Sweden
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico
[7] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[8] Univ Copenhagen, Copenhagen, Denmark
[9] UT Southwestern Med Ctr, Dallas, TX USA
[10] UCL, London, England
[11] Univ Utah Hlth, Salt Lake City, UT USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
FR-OR51
引用
收藏
页码:35 / 36
页数:2
相关论文
共 50 条
  • [41] Effect of dapagliflozin in patients with CKD depending on primary kidney disease
    Abdullaev, Sherzod
    Daminov, Botir
    Sharapov, Olimkhon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1147 - I1147
  • [42] Effect of dapagliflozin in patients with CKD depending on primary kidney disease
    Abdullaev, Sherzod
    Daminov, Botir
    Sharapov, Olimkhon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [43] APPLYING LANDMARK DECLARE, DAPA-CKD, DAPA HE AND DELIVER TRIAL FINDINGS IN US ADULTS WITH CARDIOMETABOLIC AND RENAL DISEASES: MEDICAL CARE COST -OFFSETS ASSOCIATED WITH DAPAGLIFLOZIN COMPARED TO STANDARD OF CARE
    Chang, Raymond
    Miller, Ryan
    Huang, Joanna
    Kwon, Katherine
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S155 - S155
  • [44] Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection
    Tartof, Sara Yee
    Hsu, Jin-Wen
    Wei, Rong
    Rubenstein, Kevin B.
    Hu, Haihong
    Arduino, Jean Marie
    Horberg, Michael
    Derose, Stephen F.
    Qian, Lei
    Rodriguez, Carla V.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1471 - 1478
  • [45] Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD
    Laville, Solene M.
    Gras-Champel, Valerie
    Hamroun, Aghiles
    Moragny, Julien
    Lambert, Oriane
    Metzger, Marie
    Jacquelinet, Christian
    Combe, Christian
    Fouque, Denis
    Laville, Maurice
    Frimat, Luc
    Robinson, Bruce M.
    Bieber, Brian
    Stengel, Benedicte
    De Pinho, Natalia Alencar
    Massy, Ziad A.
    Liabeuf, Sophie
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (05) : 601 - 614.e1
  • [46] Reducing Kidney Function Decline in Patients With CKD: Core Curriculum 2021
    Chen, Teresa K.
    Sperati, Christopher J.
    Thavarajah, Sumeska
    Grams, Morgan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (06) : 969 - 983
  • [47] Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: a patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials
    Moura, F.
    Wiviott, S.
    Chertow, G.
    Dwyer, J.
    Gause-Nilsson, I
    Johansson, P.
    Langkilde, A.
    McMurray, J.
    Mosenzon, O.
    Raz, I
    Rossing, P.
    Wheeler, D.
    Sabatine, M.
    Heerspink, H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2407 - 2407
  • [48] Rate of Change in Kidney Function and the Risk of Death: The Case for Incorporating the Rate of Kidney Function Decline into the CKD Staging System
    Al-Aly, Ziyad
    Cepeda, Oscar
    NEPHRON CLINICAL PRACTICE, 2011, 119 (02): : C179 - C185
  • [49] Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial
    Bartholdy, Katja Vu
    Johansen, Niklas Dyrby
    Landler, Nino
    Skaarup, Kristoffer Grundtvig
    Jensen, Jesper
    Bressendorff, Iain
    Schou, Morten
    Christensen, Jacob
    Feldt-Rasmussen, Bo
    Vaduganathan, Muthiah
    Solomon, Scott
    Haynes, Richard
    Persson, Frederik
    Rossing, Peter
    Kober, Lars
    Zannad, Faiez
    Hansen, Ditte
    Biering-Sorensen, Tor
    KIDNEY360, 2023, 4 (02): : 143 - 149
  • [50] Rate of Kidney Function Decline. and Risk of Hospitalizations in Stage 3A CKD
    Xie, Yan
    Bowe, Benjamin
    Xian, Hong
    Balasubramanian, Sumitra
    Al-Aly, Ziyad
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11): : 1946 - 1955